A Phase I Dose Escalation Trial of BI 6727 in Combination With Cisplatin or Carboplatin in Patients With Advanced or Metastatic Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 22 Mar 2015
At a glance
- Drugs Carboplatin; Cisplatin; Volasertib
- Indications Solid tumours
- Focus Adverse reactions
- 06 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 06 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Feb 2012 Planned end date changed from 1 Jan 2012 to 1 Mar 2012 as reported by ClinicalTrials.gov.